Novel Assay for Assessing ROS
Novel Assay for Assessing ROS
批准号:
7676616
负责人:
Chunqi Li
金额:
$19.4万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2011-02-28
关键词:
8-hydroxy-2&apos-deoxyguanosineAcidsAnimalsAnteriorAntibodiesApoptosisBiological AssayBrainBrain regionCell ProliferationCell physiologyCessation of lifeChronicDNADNA DamageDNA Modification ProcessDataDeoxyguanosineDevelopmentDiseaseDorsalDrug ControlsEnzyme-Linked Immunosorbent AssayEvaluationExhibitsFailureFishesFluorescenceFrequenciesGovernmentImageryLegal patentLightLocationMammalsMeasurementMethodsModelingMolecularMusNecrosisOrganOxidative StressOxygenPersonsPharmaceutical PreparationsPharmacologic SubstancePhasePhase I Clinical TrialsPlayPoisonPreclinical Drug EvaluationProcessProgressive DiseaseReactive Nitrogen SpeciesReactive Oxygen SpeciesRelative (related person)ResearchRoleStagingStaining methodStainsSystemTestingTimeTissuesToxic effectTumor PromotionWaterZebrafishbasecarcinogenesiscell growthcell transformationcostdrug developmentdrug mechanismhigh throughput screeningin vivoirradiationluminescencemethod developmentnoveloxidationpublic health relevancetumor initiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Reactive oxygen species (ROS) are known to contribute as pathogenic factors to the development of chronic progressive diseases at various stages. ROS are also involved in a variety of different cellular processes ranging from apoptosis and necrosis to cell proliferation and carcinogenesis. ROS are well recognized for playing a dual role as both deleterious and beneficial species. They are also capable of inducing DNA damage that eventually may contribute to cell transformation and tumor initiation and are also associated with tumor promotion and progression. ROS also act as primary or secondary messengers to promote cell growth or death. In Phase I research, we will develop a microplate-based zebrafish whole animal assay to assess drug-induced oxidative stress. PUBLIC HEALTH RELEVANCE: Molecular players comprise both reactive oxygen (ROS) and reactive nitrogen species (RNS), which are known to contribute as pathogenic factors to the development of chronic progressive diseases at various stages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Brain Cancer Xenotransplant Model for Drug Screening
-
批准号:7907320
-
项目类别:
-
资助金额:$19.2万
-
财政年份:2010
-
负责人:Chunqi Li
-
依托单位:
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
-
批准号:7848598
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2009
-
负责人:Chunqi Li
-
依托单位:
In Vivo Zebrafish Tyrosine Kinase ELISA
-
批准号:7540337
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2008
-
负责人:Chunqi Li
-
依托单位:
Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and Drug Safety
-
批准号:7393512
-
项目类别:
-
资助金额:$16.07万
-
财政年份:2008
-
负责人:Chunqi Li
-
依托单位:
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
-
批准号:7692940
-
项目类别:
-
资助金额:$42.58万
-
财政年份:2008
-
负责人:Chunqi Li
-
依托单位:
Phase 2 SBIR: Zebrafish Cytochrome P450 Assays for Assessing Drug Metabolism and
-
批准号:7613075
-
项目类别:
-
资助金额:$42.14万
-
财政年份:2008
-
负责人:Chunqi Li
-
依托单位:
In Vivo Zebrafish GFAP ELISA for Neurotoxicity
-
批准号:7482582
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2008
-
负责人:Chunqi Li
-
依托单位:
海外基金